Polyamine-vectored iron chelators: The role of charge

被引:20
作者
Bergeron, RJ [1 ]
Bharti, N [1 ]
Wiegand, J [1 ]
McManis, JS [1 ]
Yao, H [1 ]
Prokai, L [1 ]
机构
[1] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA
关键词
D O I
10.1021/jm048974f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The utility of polyamines as vectors for the intracellular transport of iron chelators is further described. Consistent with earlier results with polyamine analogues, these studies underscore the importance of charge in the design of polyamine-vectored chelators. Four polyamine conjugates are synthesized, two of tereplithalic acid [N-1-(4-carboxy)benzoylspermine (7) and its methyl ester (6)] and two of (S)-2-(2,4-dihydroxyphenyl)-4,5-dihydro-4-methyl-4-thiazolecarboxylic acid [(S)-4'-(HO)-DADFT] [(S)-4,5-dihydro-2-[2-hydroxy-4-(12-amino-5,9-diazadodecyloxy)phenyl]-4-methyl-4-thiazolecarboxylic acid (10) and its ethyl ester (9)]. These four molecules were evaluated in murine leukemia L1210 cells for their impact on cell proliferation (48- and 96-h IC50 values), their ability to compete with spermidine for the polyamine transport apparatus (K-i), and their intracellular accumulation. The data revealed that when neutral molecules (cargo fragments) were fixed to the polyamine vector, the conjugates competed well with spermidine for transport and were accumulated intracellularly to millimolar levels. However, this was not the case when the cargo fragments were negatively charged. Metabolic studies of the polyamine-vectored (S)-4'-(HO)-DADFTs in rodents indicated that not only did the expected deaminopropylation step occur, but also a surprisingly high level of oxidative deamination at the terminal primary nitrogens took place. Finally, the iron-clearing efficiency of the (S)-4'-(HO)-DADFT conjugates was determined in a bile-duct-cannulated rodent model. Attaching the ligand to a polyamine vector had a profound effect on increasing the iron-clearing efficiency of this chelator relative to its parent drug.
引用
收藏
页码:4120 / 4137
页数:18
相关论文
共 96 条
[11]   HBED: A potential alternative to deferoxamine for iron-chelating therapy [J].
Bergeron, RJ ;
Wiegand, J ;
Brittenham, GM .
BLOOD, 1998, 91 (04) :1446-1452
[12]   HBED: The continuing development of a potential alternative to deferoxamine for iron-chelating therapy [J].
Bergeron, RJ ;
Wiegand, J ;
Brittenham, GM .
BLOOD, 1999, 93 (01) :370-375
[13]  
Bergeron RJ, 2002, ADV EXP MED BIOL, V509, P167
[14]   Methoxylation of desazadesferrithiocin analogues: Enhanced iron clearing efficiency [J].
Bergeron, RJ ;
Wiegand, J ;
McManis, JS ;
Bussenius, J ;
Smith, RE ;
Weimar, WR .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1470-1477
[15]  
BERGERON RJ, 1984, SYNTHESIS-STUTTGART, P782
[16]   Evaluation of the desferrithiocin pharmacophores as a vector for hydroxamates [J].
Bergeron, RJ ;
McManis, JS ;
Bussenius, J ;
Brittenham, GN ;
Wiegand, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2881-2886
[17]   Desazadesmethyldesferrithiocin analogues as orally effective iron chelators [J].
Bergeron, RJ ;
Wiegand, J ;
Weimar, WR ;
Vinson, JRT ;
Bussenius, J ;
Yao, GW ;
McManis, JS .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (01) :95-108
[18]   Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives [J].
Bergeron, RJ ;
Müller, R ;
Huang, GF ;
McManis, JS ;
Algee, SE ;
Yao, H ;
Weimar, WR ;
Wiegand, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (15) :2451-2459
[19]   Polyamine analogue antidiarrheals: A structure-activity study [J].
Bergeron, RJ ;
Wiegand, J ;
McManis, JS ;
Weimar, WR ;
Smith, RE ;
Algee, SE ;
Fannin, TL ;
Slusher, MA ;
Snyder, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) :232-244
[20]   Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators [J].
Bergeron, RJ ;
Wiegand, J ;
Wollenweber, M ;
McManis, JS ;
Algee, SE ;
RatliffThompson, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) :1575-1581